Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Fungal microbiota dynamics and its geographic, age and gender variability in patients with cystic fibrosis.
Clin Microbiol Infect. 2023 Apr;29(4):539.e1-539.e7. doi: 10.1016/j.cmi.2022.11.001. Epub 2022 Nov 10.
Clin Microbiol Infect. 2023.
PMID: 36371030
Free article.
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group.
Flume PA, et al.
Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10.
Lancet Respir Med. 2021.
PMID: 33581080
Item in Clipboard
Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study.
Girón RM, Carrasco-Hernández L, Peláez A, Gómez Bonilla A; Symkevi working group.
Girón RM, et al.
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Mar;41(3):193-195. doi: 10.1016/j.eimce.2022.05.018.
Enferm Infecc Microbiol Clin (Engl Ed). 2023.
PMID: 36870735
No abstract available.
Item in Clipboard
Cite
Cite